Results -During all workloads (but not at rest) intracellular pH was higher in the patients with cystic fibrosis than in the controls. The linear least square fit for Y = a -bX showed high correlations in both groups; the slope b was 19% lower in the patients than in the controls (11'8% v 14'5% MVC/In M; 95% confidence interval for difference 0 3 to 5.0).
Abstract
Background -Exercise intolerance in patients with cystic fibrosis is commonly attributed to reduced pulmonary and nutritional status. The possible role of diminished efficiency of mitochondrial oxidative phosphorylation in relation to skeletal muscle performance was investigated in patients with cystic fibrosis. Methods -In vivo synthesis of ATP in skeletal muscle during submaximal exercise was studied in eight patients with cystic fibrosis aged 12-17 years, and in 19 healthy control subjects aged years. The intracellular pH and concentrations of phosphate compounds were calculated at four steady states from phosphorus-31 labelled nuclear magnetic resonance spectroscopy measurements in the forearm muscle during bulb squeezing in an exercise protocol. Normalised Results -During all workloads (but not at rest) intracellular pH was higher in the patients with cystic fibrosis than in the controls. The linear least square fit for Y = a -bX showed high correlations in both groups; the slope b was 19% lower in the patients than in the controls (11'8% v 14 The study was approved by the medical ethical committee of our hospital and informed consent was obtained from all subjects.
THEORETICAL MODELLING
For a quantitative analysis of phosphorus-31 nuclear magnetic resonance (3'P-NMR) measurements in human skeletal muscle a thermodynamic model of adenine nucleotide feedback control of oxidative phosphorylation was used as previously described." Briefly, the model is based on the theory of mosaic non-equilibrium thermodynamics'2 which proposes that, with certain assumptions such as negligible contribution of glycolytic ATP production, the mitochondrial-driven ATP flow can be described by a quasilinear function of the free energy force. This energy force of cytosolic ATP hydrolysis can be derived from the substrate and product concentrations in mitochondrial ATP production as mathematically expressed by the logarithm of the phosphorylation potential3 '4 - 10.5 11.5 Energy force (-In M) were considered significant if p<a tailed). 
Is
Results Figure 1 depicts the NMR spectra of a patient fibrosis with cystic fibrosis and a control subject. Changes in Pi and PCr levels in the muscle at comparable power output levels are clearly more pronounced in the patient than in the control subject. This indicates that a greater perturbation of the cellular energy force is required in the patient to generate a similar amount of power. The results of calculated free energy force and power output of the sampled forearm muscle for all measurements in both groups of subjects and the linear regression lines are depicted in fig 2. Linear least squares fit comparisons of muscle performance in the muscle are given in table 2. Pearson correlation coefficients indicated that a good fit was obtained for both groups (p<0001). The slope of the 12.5 linear regression equation in this model for the energy force-flow relationship of patients with cystic fibrosis was 19% lower than in the con-,nuscle fibres trols (b= 11-8% versus 14i5% MVC/ln M eight respectively, p<005). The vertical distance s of the between the linear regression lines at the mean value offree energy force in the control subjects (10 74 -ln M) is another parameter reflecting ([ATP] x efficiency of oxidative work performance in the r]), where sampled muscle. At the fitted power output -ntration.17 level of approximately 25% MVC in the control d from the subjects the patients with cystic fibrosis susCr peaks.'8 tained an output of 19% MVC, demonstrating discarded a relative decrease of 25% in power output indicating in the patients compared with the controls 7 0 was no (p<0001). Likewise, the vertical distance at the mean value of the free energy force was also significantly lower in the patients than in the six age-matched control subjects (p<005). Within the control group no significant differoups were ences in mitochondrial performance were r work was found between the subjects aged more than or ire models less than 18 years. put to the The calculated intracellular pH at rest did rithin each not differ between patients with cystic fibrosis calculating and controls, but during exercise pHi was een group higher in the patients than in the controls istance be-(p<0 01). Acidosis (pHi <6-90) did not occur ;cribed by in any of the patients during exercise.
differences )-05 (twoDiscussion
In vivo "P-NMR spectroscopy during exercise can be used to study the efficiency of mitoand power chondrial ATP synthesis from oxidative phosd contrl phorylation in relation to work performance of skeletal muscle. In the present study we applied 19) a quantitative method" to measure mitochondrial performance which corrects for (7) differences in nutritional status between sub-5 (0 6) jects. For that purpose, workloads in the ex-94 (<0 001) ercise protocol were tailored to individual maximal power output of the sampled muscle.
In previous "P-NMR spectroscopy studies of skeletal muscle metabolism in patients with ,en(eM force chronic obstructive pulmonary disease5620
.111 (M) of the to the pooled other parameters of mitochondrial capacity it the mean of were studied and they were not always tailored s a fitted Y in to individual maximal power output. 18 years Y= In our protocol the metabolic status of the forearm muscle sampled with "P-NMR spec-troscopy was related to sustained power output using a thermodynamic model of ATP production. This approach showed excellent linear least square fits in the patients with cystic fibrosis as well as in the control subjects, and is in agreement with other experiments and theoretical expectations. 1221 Statistically significant differences in slope and power output at comparable and arbitrary levels of free energy were found, indicating that the efficiency of oxidative ATP synthesis in exercising forearm muscle was 19-25% lower in the patients with cystic fibrosis than in healthy control subjects. Before we draw conclusions on the clinical relevance of these findings, we should address whether the results could be due to experimental bias. In our thermodynamic model we assumed that changes in the redox state of the muscle cells do not substantially contribute to control of the rate of mitochondrial ATP synthesis.2' Under hypoxic conditions and during exercise the concentrations of pyruvate and NADH in the cell could change the cytosolic redox state and activation of the lactate dehydrogenase complex with increased lactate production would ensue. With regard to the former, hypoxaemia was not a concern in the patients with cystic fibrosis. Although the resting oxygen saturation in the patients did not reach 100% (table 1) , the actual levels of resting oxygen saturation exceeded the Michaelis constant of mitochondria for oxygen more than tenfold.22 Also, blood gas tensions (and plasma lactate concentrations, unpublished data) at rest in all patients were within normal limits. With regard to the latter, the absence of a severe drop in pHi during exercise indicates that no substantial lactate production occurred over the range of workloads studied (maximal pHi change = 0 1 units in patients and controls).
The main finding of our study was that the efficiency of skeletal muscle to perform work was up to 25% lower in the patients with cystic fibrosis than in controls (figs 1 and 2). Since our measurements addressed the balance between ATP free energy utilisation by the contractile elements and ATP free energy production by the mitochondria, the result may be explained by a diminished efficiency of the process on either side of the free energy balance. With respect to a diminished efficiency of force generation during contraction, we cannot exclude this explanation of our findings. However, with regard to impaired in vivo mitochondrial function in skeletal muscle of patients with cystic fibrosis, evidence for mitochondrial abnormalities has been reported in the literature. Specifically, in an in vitro study ofleucocyte mitochondria in patients with cystic fibrosis Dechecci and coworkers found that properties of complex I of the respiratory chain were significantly altered.8 Changes in mitochondrial function in patients with cystic fibrosis may therefore be secondary to their diminished clinical status -for example, activity levels -or nutritional status -for example, rate of protein synthesis.
The gene responsible for the clinical manifestations in cystic fibrosis (the cystic fibrosis transmembrane conductance regulator involved in transmembrane chloride transport in epithelial tissues) has not until now been shown to be expressed in skeletal muscle. It seems unlikely that the reduced efficiency of work performance in the forearm muscle of patients with cystic fibrosis could be attributed to a primary effect of the mutated gene.
In conclusion, the results ofthis study indicate that efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis is reduced by 19-25%. A decrease in mitochondrial function secondary to clinical or nutritional factors which affects mitochondrial density and metabolism may be the explanation for this finding. Further studies of muscle mitochondrial function inpatients with cystic fibrosis at different stages of this disease and at higher levels of work output are indicated.
